Alert: New Earnings Report (11/2/23)-BioCryst Pharmaceuticals Inc (NASDAQ: BCRX).
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) has reported a loss for its third fiscal quarter (ending September 30) of $-0.19 versus a loss $-0.23 for the same period a year ago. This result was in line […]